Our Researcher
Dr. Fradet-Turcotte and her team are studying the cell mutations found in patients with hereditary breast cancer. Their goal is to better understand the ability of cancer cells to resist certain treatments and therefore enable the design of better treatment strategies that use the patient’s genome information to provide personalized therapies.
Centre de recherche du CHU de Québec : Université Laval, in partnership with Cancer Research Society
Related Researchers
Providing financial support for breast cancer research has always been a driving force in CURE’s mission. Through strategic partnerships with Canada’s top institutions, the foundation invests in basic, translational and clinical research, all with the goal of improving treatment and finding a cure.
Dr. Mark Clemons
Clinical Investigator at the Ottawa Hospital Research Institute (Cancer Therapeutics Program), staff medical oncologist (Ottawa Hospital Cancer Centre) and Professor of Medicine (University of Ottawa)
Dr. Kathryn Isaac
Dr. Patricia Clugston VGH & UBC Hospital Foundation Chair in Breast Reconstruction Surgery
